Dysregulation of the PI3K pathway is frequently observed in human cancers, comprising of amplification and somatic mutations of PIK3CA, deletion or inactivation of PTEN and amplification or mutation of AKT isoforms (reviewed in Janku et al. [52]). This evidence concerns the gene PIK3CA and cancer.